Teva Pharmaceutical Industries Ltd (TEVA) is up on Thursday morning, with the stock gaining 1.31% pre-market to 7.74. TEVA’s short-term technical score of 19 indicates that the stock has traded less bullishly over the past month than 81% of stocks in the market. In the Drug Manufacturers – Specialties and Generics industry, which ranks 134 out of 146 industries, TEVA ranks above 37% of the stock. Teva Pharmaceutical Industries Ltd has fallen 9.59% over the past month, closing at $9.08 on May 26. During this period, the stock fell as low as $7.63 and as low as $9.52. TEVA has an average buy recommendation for analysts. The company has an average price target of $10.13.
Teva Pharmaceutical Industries Ltd has a long-term technical ranking of 85. This means that trading over the past 200 trading days has placed the company in the top half of the stock with 15% of the market up. In the Drug Manufacturers – Specialty & Generic industry which is number 122 by this metric, TEVA ranks better than 122% of the stock.
Important dates for investors in TEVA:
-Teva Pharmaceutical Industries Ltd is expected to release its results on 07/27/2022. Over the past 12 months, the company reported EPS of -$3.49. -We do not have a fixed dividend date for Teva Pharmaceutical Industries Ltd at this time. Click here for the full report on Teva Pharmaceutical Industries Ltd (TEVA)
Stay in the know
Subscribe to our daily morning update newsletter and never miss market news, moves and more.